Bobbianna Neubert-Langille

Bobbianna Neubert-Langille is an accomplished professional in regulatory affairs with extensive experience in the pharmaceutical industry. Currently serving as Director of Regulatory Affairs, CMC at Biogen since July 2021, Bobbianna oversees early-phase small molecule development, managing a team of CMC regulatory leads and strategizing for clinical phases. Prior experience includes serving as Director of Regulatory Affairs CMC at Alkermes from February 2017 to July 2021, where Bobbianna led regulatory submissions for biologics and small molecules. Bobbianna's tenure at Vertex Pharmaceuticals from 2005 to February 2017 included roles ranging from Head of GMP Operations, where oversight of compliance and project management was essential, to significant involvement in regulatory inspections and material management. Bobbianna holds a PhD in Chemistry from Brandeis University and a Bachelor's degree in Organic Chemistry from Boston University, along with a Certificate in Biotechnology Project Management from the University of Washington.